Categories: News

Nephros Announces Third Quarter 2021 Financial Results Conference Call

SOUTH ORANGE, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its third quarter financial results on Thursday, November 4, 2021 after market close and will host a conference call that same day at 4:30 PM ET.

Participants may dial into the call as follows:
Domestic access: 1-844-808-7106
International access: 1-412-317-5285

Upon joining, please ask to be joined into the Nephros conference call.

A replay of the call can be accessed until November 11, 2021 at 1-877-344-7529or 1-412-317-0088for international callers and entering replay access code: 10160005. 

An audio archive of the call will be available shortly after the call on the Nephros investor relations page at https://investors.nephros.com/events/.

About Nephros
Nephros, Inc. is a company committed to improving the human relationship with water through leading, accessible technology. We provide innovative filtration and pathogen detection as part of an integrated approach to water safety that combines science, solutions, and support services. Nephros products serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency responses for water management. For more information about Nephros, please visit www.nephros.com.

Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com
www.pcgadvisory.com

Andy Astor, President and CEO
Nephros, Inc.
(201) 345-0824
andy@nephros.com
www.nephros.com

Staff

Recent Posts

FendX Reminds Shareholders of Webinar on April 11, 2024 to Showcase Recent Achievements and Provides Corporate Update

Oakville, Ontario--(Newsfile Corp. - April 8, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

57 mins ago

ProAssurance Announces Dates for Release of First Quarter 2024 Results Release and Investor Teleconference

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended March 31, 2024…

2 hours ago

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of…

2 hours ago

Board-Certified and Highly Accomplished Active Duty Military Ophthalmologist Now Treating Patients at LasikPlus Lexington

LEXINGTON, KY / ACCESSWIRE / April 8, 2024 / Kentucky-based ophthalmologist and LASIK eye surgeon…

2 hours ago

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)

Promising preclinical results obtained in obesity support the OBA Phase 2 clinical study expected to…

2 hours ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023

WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company")…

2 hours ago